Leerink Partners stays Outperform on Mereo BipPharma Group (MREO) despite mixed data

March 19, 2026 2:56 PM

Leerink Partners analyst Joseph Schwartz reiterated an Outperform rating and $2.00 price target on Mereo BipPharma Group (NASDAQ: MREO)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found